Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dax Kurbegov, MD
Sarah Cannon
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sarah Cannon
Thousand Oaks, California, United States
- Sarah Cannon
Denver, Colorado, United States
- Sarah Cannon
Fort Walton Beach, Florida, United States
- Sarah Cannon
Ocala, Florida, United States
- Sarah Cannon
Pensacola, Florida, United States
- Sarah Cannon
Augusta, Georgia, United States
- Sarah Cannon
Macon, Georgia, United States
- Sarah Cannon
Savannah, Georgia, United States
- Sarah Cannon
Kansas City, Kansas, United States
- Sarah Cannon
Overland Park, Kansas, United States
- Sarah Cannon
Independence, Missouri, United States
- Sarah Cannon
Las Vegas, Nevada, United States
- Sarah Cannon
Nashville, Tennessee, United States
- Sarah Cannon
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Nov 2019
- Primary completion
- 29 Jan 2021
- Completion
- 29 Jan 2021
- Last update posted
- 14 Jun 2024
- Registered enrollment
- 6,400
- Registry id
- NCT04213326
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.